Functional drug sensitivity and resistance profiling of AML patient cells defines a disease-specific combination of druggable signal addictions




Pemovska T, Yadav B, Karjalainen R, Kulesskiy E, Kontro M, Majumder MM, Turunen L, Lindenschmidt I, Lehto A, Knowles J, Heckman C, Porkka K, Aittokallio T, Kallioniemi O, Wennerberg K

PublisherAMER ASSOC CANCER RESEARCH

2013

Cancer Research

CANCER RESEARCH

CANCER RES

73

8

1

0008-5472

DOIhttps://doi.org/10.1158/1538-7445.AM2013-5588




Last updated on 2024-26-11 at 17:23